Otonomy Inc Quick Ratio (OTIC) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Otonomy Inc   (NASDAQ: OTIC)

Otonomy Inc 's Quick Ratio

OTIC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 1.85 a new company low.

Within Major Pharmaceutical Preparations industry 431 other companies have achieved higher Quick Ratio than Otonomy Inc in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 722 to 1781.

Explain Quick Ratio?
How much Cash & cash equivalents OTIC´s has?
What are OTIC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OTIC Quick Ratio (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3
Y / Y Current Liabilities Change 239.25 % 47.01 % -11.81 % 14.87 % -15.43 %
Y / Y Cash & cash equivalent Change -53.91 % -45.7 % -14.84 % -10.34 % -7.82 %
Quick Ratio MRQ 1.85 6.52 9.59 8.72 13.6
OTIC's Total Ranking # 1781 # 722 # 465 # 1500 # 438
Seq. Current Liabilities Change 166.39 % 24.32 % -26.13 % 38.68 % 15.43 %
Seq. Cash & cash equivalent Change -24.46 % -15.47 % -18.78 % -11.12 % -11.02 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 432
Healthcare Sector # 761
Overall Market # 1781


Quick Ratio Statistics
High Average Low
33.66 15.73 1.85
(Jun 30 2015)   (Sep 30 2022)




Financial Statements
Otonomy Inc 's Current Liabilities $ 22 Millions Visit OTIC's Balance sheet
Otonomy Inc 's Cash & cash equivalent $ 40 Millions Visit OTIC's Balance sheet
Source of OTIC's Sales Visit OTIC's Sales by Geography


Cumulative Otonomy Inc 's Quick Ratio

OTIC's Quick Ratio for the trailling 12 Months

OTIC Quick Ratio

 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 67.11 % 6.05 % -10.97 % -10.13 % -37.89 %
Y / Y Cash & cash equivalent TTM Growth -32.32 % -20.42 % 9.99 % 24.29 % 40.98 %
Quick Ratio TTM 5.16 9.35 11.88 11.9 12.73
Total Ranking TTM # 668 # 525 # 472 # 546 # 479
Seq. Current Liabilities TTM Growth 51.07 % 9.52 % -3.11 % 4.24 % -4.13 %
Seq. Cash & cash equivalent TTM Growth -16.74 % -13.75 % -3.26 % -2.59 % -2.1 %

Quick ratio ranking by company, industry and sector >> Back to OTIC Financial Strength Comparisons >> Go to Compare OTIC Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q3 2022 to $21.72 millions, cumulative Quick Ratio decreased to 5.16 below the Otonomy Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 555 other companies have achieved higher Quick Ratio than Otonomy Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2022 from 655 to 4316.

Explain Quick Ratio?
How much Cash & cash equivalents OTIC´s has?
What are OTIC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 556
Healthcare Sector # 1111
Within the Market # 1781


trailing twelve months Quick Ratio Statistics
High Average Low
28.81 7.6 1.59
(Jun 30 2015)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Beyondspring Inc   5.07 $ 37.268  Millions$ 7.352  Millions
Revance Therapeutics Inc   5.07 $ 378.627  Millions$ 74.732  Millions
Connect Biopharma Holdings Limited  5.06 $ 79.010  Millions$ 15.624  Millions
Werewolf Therapeutics Inc   5.05 $ 140.450  Millions$ 27.800  Millions
Deciphera Pharmaceuticals Inc   5.04 $ 364.577  Millions$ 72.298  Millions
Bellicum Pharmaceuticals Inc   5.00 $ 28.756  Millions$ 5.748  Millions
Amylyx Pharmaceuticals Inc   4.98 $ 162.593  Millions$ 32.647  Millions
Plx Pharma Inc   4.97 $ 25.834  Millions$ 5.200  Millions
Korro Bio Inc   4.97 $ 99.347  Millions$ 20.003  Millions
Igc Pharma Inc   4.93 $ 6.816  Millions$ 1.382  Millions
Virpax Pharmaceuticals Inc   4.89 $ 20.563  Millions$ 4.208  Millions
Neximmune Inc   4.88 $ 45.860  Millions$ 9.394  Millions
Tg Therapeutics Inc   4.83 $ 175.942  Millions$ 36.447  Millions
Decibel Therapeutics Inc   4.79 $ 111.946  Millions$ 23.374  Millions
Novabridge Biosciences  4.75 $ 500.121  Millions$ 105.191  Millions
Verastem Inc   4.75 $ 103.976  Millions$ 21.873  Millions
Ampio Pharmaceuticals inc   4.72 $ 16.947  Millions$ 3.592  Millions
Bridgebio Pharma Inc   4.68 $ 558.315  Millions$ 119.194  Millions
Proqr Therapeutics N v   4.49 $ 106.148  Millions$ 23.645  Millions
Galmed Pharmaceuticals Ltd   4.46 $ 13.785  Millions$ 3.094  Millions
Praxis Precision Medicines Inc   4.42 $ 123.740  Millions$ 28.006  Millions
Imunon Inc   4.41 $ 37.352  Millions$ 8.465  Millions
Trevena inc   4.36 $ 40.392  Millions$ 9.257  Millions
Adial Pharmaceuticals Inc   4.34 $ 5.753  Millions$ 1.327  Millions
Regulus Therapeutics Inc   4.31 $ 45.324  Millions$ 10.521  Millions
Revelation Biosciences Inc   4.24 $ 6.195  Millions$ 1.463  Millions
Ultragenyx Pharmaceutical Inc   4.18 $ 888.675  Millions$ 212.584  Millions
Spyre Therapeutics Inc   4.17 $ 73.676  Millions$ 17.678  Millions
Gt Biopharma Inc   4.14 $ 20.784  Millions$ 5.025  Millions
Ocular Therapeutix Inc   4.13 $ 120.950  Millions$ 29.269  Millions

Date modified: 2026-09-08T15:22:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.